Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing-Reference-Cited by-同舟云学术

Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing

Published:2017-10 Issue:S1 Volume:17 Page:
ISSN:1471-2318
Container-title:BMC Geriatrics
language:en
Short-container-title:BMC Geriatr

Author:

Sommerauer Christina,Schlender Lisa,Krause Mark,Weißbach Sabine,Rieckert Anja,Martinez Yolanda V,Reeves David,Renom-Guiteras Anna,Kunnamo Ilkka,Sönnichsen Andreas

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1186/s12877-017-0573-6.pdf

Reference87 articles.

1. Go AS, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.

2. Benjamin EJ, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–52.

3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8.

4. Hart RG, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492–501.

5. Roskell NS, et al. Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies. Europace. 2013;15(6):787–97.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials;GeroScience;2023-06-01

2. Potentially inadequate medications in the elderly: PRISCUS 2.0—first update of the PRISCUS list;Deutsches Ärzteblatt international;2023-01-09

3. Relationship of warfarin versus DOACs with thrombogenic milieu in the left atrium among patients with nonvalvular atrial fibrillation;Echocardiography;2022-02-08

4. Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers;Expert Review of Cardiovascular Therapy;2021-08-13

5. Review of the top 5 geriatrics studies of 2018-2019;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2021-06-13